- Home
- RLGT vs KMDA Comparison
RLGT vs KMDA Comparison
Compare RLGT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | KMDA |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.6M | 385.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RLGT | KMDA |
|---|---|---|
| Price | $6.33 | $7.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $8.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 159.1K | 93.2K |
| Earning Date | 02-09-2026 | 11-10-2025 |
| Dividend Yield | N/A | ★ 2.84% |
| EPS Growth | ★ 72.35 | 30.41 |
| EPS | 0.31 | ★ 0.35 |
| Revenue | ★ $925,786,000.00 | $174,787,000.00 |
| Revenue This Year | $3.77 | $14.79 |
| Revenue Next Year | $3.51 | $10.74 |
| P/E Ratio | $20.39 | ★ $20.03 |
| Revenue Growth | ★ 16.42 | 10.36 |
| 52 Week Low | $5.44 | $5.54 |
| 52 Week High | $7.94 | $9.16 |
Technical Indicators
Market Signals| Indicator | RLGT | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 50.57 |
| Support Level | $6.31 | $6.98 |
| Resistance Level | $6.55 | $7.17 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 6.90 | 22.77 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.